Survivorship Care Plans in a Community Oncology Practice

NCT03028584 | Completed DMC

• 5 other identifiers: UW16029P30CA0145202016-0760A534260SMPH\MEDICINE\HEM-ONC
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

This is a two part observational study evaluating the feasibility of implementing an EHR-based model within a community oncology practice.

Conditions

Breast Cancer; Prostate Cancer; Colorectal Cancer

Keywords

BrCa; PrCa; CRCa

Outcome Measures

Primary Outcomes (1)

• EHR-based SCPs and care planning

  Asses whether barriers to EHR-based SCPs and care planning have been mitigated, based on clinician survey.

  Up to 2 years

Secondary Outcomes (4)

• Feasibility of providing EHR-based care planning, measured by SCP provision rates

  Up to 2 years

• Feasibility of providing EHR-based care planning, measured by the EHR

  Up to 2 years

• Self-reported change in satisfaction, using survey

  Up to 2 years

• Impact of providing EHR-based care planning

  Up to 2 years

Study Arms (2)

Clinicians

Observe up to N=10 clinicians. Observations will include: 1. Oncology history and care plan development by clinicians including use of EHR technology to develop care plans and methods used to secure necessary information for care plan creation 2. Provision and coordination of survivorship care occurring during care team meetings, discussions among clinicians, and survivor visits with clinicians, especially visits in which a care plan is provided to a survivor 3. Clinician seeking survivorship related information or resources through use of technology or discussion with other clinicians 4. Survivorship work or tasks performed by the clinician including adding, modifying or extracting information from the EHR and adding or modifying information in the care plan

Behavioral: Survey

Clinicians and Patients

Surveys of N=30 breast cancer, colon cancer, and prostate cancer patients. Subjects will complete 1st survey electronically in-clinic. Subjects will either be e-mailed or mailed a survey at 4 weeks. Survey of clinicians will be sent via e-mail.

Behavioral: Survey

Interventions

Survey BEHAVIORAL

Subjects (cancer patients and clinicians) will complete up to 2 surveys.

Clinicians; Clinicians and Patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Clinicians who provide care for breast, colon, or prostate patients. Cancer patients/survivors of breast cancer (BrCa), prostate (PrCa), or colorectal (CRCa) cancer.

You may qualify if:

• Clinicians: Provide cancer care to BrCa, CRCa or PrCa
• Clinicians: Are a physician, advanced practice practitioner, nurse, or equivalent
• Patients: Have a diagnosis of breast, colorectal, or prostate cancer for which and EHR-based SCP will be provided
• Patients: Have been treated with curative intent (e.g. surgery, chemotherapy and/or radiation therapy) for a Stage 1-3 cancer diagnosis
• Patients: Have received some part of active cancer treatment
• Patients: Have complete active treatment (defined as surgery, chemotherapy, and/or radiation therapy). HER2-based and endocrine therapies may be ongoing and do NOT need to have been completed

You may not qualify if:

• Unable to complete or unwilling to answer questions in English
• Patients: Received all active cancer treatment elsewhere (e.g. "observation - only" patients)
• Patients: Have metastatic cancer

Sponsors & Collaborators

• University of Wisconsin, Madison: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

UW Cancer Center at ProHealth Care

Waukesha, Wisconsin, 53188, United States

Location

Related Links

• UW Carbone Cancer Center Home Page

MeSH Terms

Conditions

Breast Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Genital Neoplasms, Male; Urogenital Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases; Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Amyé Tevaarwerk, MD

  University of Wisconsin, Madison

  PRINCIPAL INVESTIGATOR

• Mary Sesto, PT, PhD

  University of Wisconsin, Madison

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 10, 2016
• First Posted: January 23, 2017
• Study Start: September 11, 2017
• Primary Completion: February 28, 2018
• Study Completion: March 23, 2018
• Last Updated: November 18, 2019

Record last verified: 2018-10

Locations

US (1)